Bitcoin price today: slips below $88k as rebound stalls ahead of key US data - Bitcoin fell on Tuesday, cutting short a recent rebound as traders remained largely cautious towards cryptocurrencies, with anticipation of key U.S. economic readings adding to the risk-averse mood.
Gold rally not over: UBS targets $5,400 - UBS has extended its gold price forecast by one quarter, setting a target of $5,400 per ounce by the end of September 2027.
European stock markets showed mixed performance at the start of trading on Tuesday.
European stocks traded mixed in early Tuesday dealings, with key regional developments including a jump in Novo Nordisk shares after the drugmaker secured regulatory approval for its GLP-1 obesity pill, and fresh data showing a decline in Tesla’s European sales in November.
As of 08:08 GMT, the DAX index in Germany climbed 0.1%, the CAC 40 in France fell 0.07%, and the FTSE 100 in the U.K. was flat.
Novo Nordisk’s Wegovy pill gets FDA approval
Novo Nordisk A/S (NYSE:NVO) said that the U.S. Food and Drug Administration has approved its Wegovy pill as the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight management.
The once-daily oral semaglutide 25 mg pill is approved to reduce excess body weight, maintain weight reduction long-term, and reduce the risk of major adverse cardiovascular events.
Tesla Europe sales contract in November, BYD gains market share
Tesla Inc’s sales in Europe declined in November, while Chinese competitor BYD Co. Ltd.-H (HK:1211) strong growth and expanded its market share in the region.
Tesla’s sales across the European Union, the Euro Free Trade Association, and the UK dropped 11.8% year-on-year to 22,801 units in November, according to data released Tuesday by the European Automobile Manufacturers’ Association.
The American electric vehicle maker’s market share in the region fell to 2.1% from 2.5% a year earlier. Despite the annual decline, Tesla’s November market share represented an improvement from the 0.6% recorded in October.
Meanwhile, BYD posted significant year-on-year growth in the European market, continuing to strengthen its position in the region’s electric vehicle sector.
Norway’s oil output exceeds forecast in November
Norway’s oil production averaged 1.882 million barrels per day in November 2025, surpassing the Norwegian Offshore Directorate’s forecast by 4.3%, according to preliminary figures released Tuesday.
The total petroleum production reached 2.09 million barrels per day, which includes oil, natural gas liquids (NGL), and condensate. NGL contributed 190,000 barrels per day to the total, while condensate added 19,000 barrels daily.
Gas sales for November amounted to 10.8 billion standard cubic meters (GSm3), representing an increase of 0.4 GSm3 compared to October’s figures.
Cevian Capital raises stake in Akzo Nobel
Activist investor Cevian Capital has increased its stake in Dutch paint manufacturer Akzo Nobel NV (AS:AKZO) to 10.15%, according to a filing published Tuesday by the Dutch market regulator AFM.
The filing revealed that the Cevian Capital II GP fund owned the increased stake in the Dulux paints maker as of December 19.
This represents a significant increase in Cevian’s position in the Dutch company, though the filing did not disclose the investor’s previous ownership level.
Ryanair fined €255 million by Italian regulator for market abuse
Italy’s Competition Authority has imposed a fine of over €255 million on Ryanair DAC and its parent company Ryanair Holdings PLC (LON:0RYA) for abusing its dominant market position to obstruct travel agencies.
The penalty comes after an investigation determined that Ryanair had implemented an abusive strategy against both online and traditional travel agencies. The anti-competitive practices occurred over a two-year period, starting in April 2023 and continuing through at least April 2025.
The Italian regulator found that the airline had used its market dominance to hinder travel agencies’ operations, though details of the abusive tactics were not provided in the announcement.